PowderMed Report issue

For profit Phase 1
Founded: Oxford United Kingdom (2004)
Status: Acquired by Pfizer (2006)

Organization Overview

First Clinical Trial
2004
NCT00274300
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2006

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hepatitis (Phase 1)

Hepatitis A (Phase 1)

Hepatitis B (Phase 1)

Hepatitis B, Chronic (Phase 1)

Hepatitis, Chronic (Phase 1)

Herpes Genitalis (Phase 1)

Influenza, Human (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 6
  • # of Trial APIs: 8